Author:
Hou Xuwei,Hu Zhaohui,Huang Xiaohua,Chen Yan,He Xiuying,Xu Haiying,Wang Ningfu
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Drug Discovery,Molecular Medicine
Reference42 articles.
1. Zhan S, Liu M, Yao W, Hu Y, Li L, Zhu G, Sun N, Dai L (2002) Prevalence and relevant factors on echocardiographic left ventricular hypertrophy among community-based hypertensive patients in Shanghai. Zhonghua Liu Xing Bing Xue Za Zhi 23(3):182–185
2. Mancia G, Bombelli M, Facchetti R, Madotto F, Corrao G, Trevano FQ, Giannattasio C, Grassi G, Sega R (2008) Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population. J Hypertens 26(8):1602–1611
3. Petrovic D, Stojimirovic B (2008) Left ventricular hypertrophy in patients treated with regular hemodialyses. Med Pregl 61(7–8):369–374
4. Kaplinsky E (1994) Significance of left ventricular hypertrophy in cardiovascular morbidity and mortality. Cardiovasc Drugs Ther 8(Suppl 3):549–556
5. Tovillas-Moran FJ, Vilaplana-Cosculluela M, Zabaleta-del-Olmo E, Dalfo-Baque A, Galceran JM, Coca A (2010) Cardiovascular morbidity and mortality and electrocardiographic criteria of left ventricular hypertrophy in hypertensive patients treated in primary care. Med Clin (Barc) 135(9):397–401
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献